• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: LUTONIX, INC LUTONIX 035AV DRUG COATED PTA DILATION CATHETER; DRUG COATED BALLOON PTA CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

LUTONIX, INC LUTONIX 035AV DRUG COATED PTA DILATION CATHETER; DRUG COATED BALLOON PTA CATHETER Back to Search Results
Model Number 9010
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Thrombosis/Thrombus (4440); Restenosis (4576)
Date of Event 11/28/2023
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported through the results of a clinical trial that three months and seventeen days post an index procedure completion using a drug coated balloon catheter in the cephalic vein, the subject developed a serious adverse event of vascular occlusion due to access thrombosis which required an additional arteriovenous access circuit reintervention.Thrombectomy and fistula ligation were performed to treat access thrombosis.Treatment re-intervention was not successful due to abandoned access.Furthermore, a new access was created using permanent dialysis catheter due to reassessment need for central venous catheter.Reportedly, there have been no documented device deficiencies reported for this subject to date.The current status of the patient is unknown.
 
Additional Manufacturer Narrative
H10: manufacturing review: the device history records have been reviewed and this lot met all release criteria.There was nothing found to indicate there was a manufacturing related cause for this event.Investigation summary: the physical device was not returned for evaluation.No photos were provided for review.Therefore, the investigation is inconclusive for the reported failure as no objective evidence was provided for review.Based upon the available information, the definitive root cause is unknown.Labeling review: as the reported event did not allege a labeling or use related issue, a labeling review is not required.H10: d4 (expiration date: 06/2025).H11: section a through f ¿ the information provided by bd represents all the known information at this time.Despite good faith efforts to obtain additional information, the complainant/reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.H3 other text : device not returned.
 
Event or Problem Description
It was reported through the results of a clinical trial that three months and seventeen days post an index procedure completion using a drug coated balloon catheter in the cephalic vein, the subject developed a serious adverse event of vascular occlusion due to access thrombosis, target lesion restenosis which required an additional arteriovenous access circuit reintervention.Thrombectomy and fistula ligation were performed to treat access thrombosis.Treatment re-intervention was not successful due to abandoned access.Furthermore, a new access was created using permanent dialysis catheter due to reassessment need for central venous catheter.Reportedly, there have been no documented device deficiencies reported for this subject to date.Av access circuit re-intervention was performed for creation of right arm radiocephalic fistula, for creation of permanent access, due to occlusion in previous fistula.The current status of the patient is unknown.
 
Additional Manufacturer Narrative
H11: manufacturing review: the device history records have been reviewed, and this lot met all release criteria.There was nothing found to indicate there was a manufacturing related cause for this event.Investigation summary: the physical device was not returned for evaluation.No photos were provided for review.Therefore, the investigation is inconclusive for the reported failure as no objective evidence was provided for review.Based upon the available information, the definitive root cause is unknown.Labeling review: as the reported event did not allege a labeling or use related issue, a labeling review is not required.B5, d4 (unique identifier (udi) #), h6 (patient, component, method).Section a through f ¿ the information provided by bd represents all the known information at this time.Despite good faith efforts to obtain additional information, the complainant/reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
LUTONIX 035AV DRUG COATED PTA DILATION CATHETER
Common Device Name
DRUG COATED BALLOON PTA CATHETER
Manufacturer (Section D)
LUTONIX, INC
9409 science center dr
new hope MN 55428
Manufacturer (Section G)
C.R. BARD, INC. (GFO)
289 bay road
queensbury 12804
Manufacturer Contact
brett curtice
800 w. rio salado pkwy
tempe, AZ 85281
4803032689
MDR Report Key18867449
Report Number3006513822-2024-00009
Device Sequence Number7879609
Product Code PRC
UDI-Device Identifier00801741135460
UDI-Public(01)00801741135460(11)230721(17)250612(10)GFHR0974
Combination Product (Y/N)N
Initial Reporter StateTX
Initial Reporter CountryUS
PMA/510(K) Number
P170003
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2023
Reporter Type Manufacturer
Report Source Other,Study
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 07/08/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date06/12/2025
Device Model Number9010
Device Catalogue NumberLX3575860V
Device Lot NumberGFHR0974
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 02/21/2024
Supplement Date Received by Manufacturer07/13/2025
Initial Report FDA Received Date03/08/2024
Supplement Report FDA Received Date07/15/2025
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured07/21/2023
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age43 YR
Patient SexMale
Patient Weight94 KG
Patient EthnicityHispanic
Patient RaceWhite
-
-